Table 1.
Main treatment planning and dosimetric data.
| PT 1 | PT 2 | PT 3 | PT 4 | PT 5 | PT 6 | PT 7 | PT 8 | PT 9 | PT 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) |
72 | 78 | 84 | 90 | 80 | 86 | 75 | 83 | 77 | 79 |
| Sex | F | F | F | M | F | M | F | F | M | F |
| CTV tot (right plus left) (cc) |
25.31 | 12.4 | 16.3 | 15.86 | 25.12 | 15.83 | 28.95 | 18.68 | 48.05 | 29.81 |
| ITV tot (cc) |
59.10 | 37.3 | 38.7 | 44.55 | 50.56 | 32.58 | 36.57 | 31.26 | 68.09 | 44.65 |
| ITV tot cropped (cc) |
54.10 | 35.2 | 36 | 40.22 | 39.7 | 28.21 | 29.19 | 25.58 | 63.9 | 39.13 |
| PTV tot (right plus left) (cc) |
78.24 | 55 | 58.9 | 56.6 | 90.69 | 49 | 48.2 | 43.11 | 90.15 | 59.46 |
| PTV tot cropped (cc) |
69.88 | 47.3 | 53.5 | 51.71 | 71.89 | 42.3 | 43.8 | 38 | 89.6 | 56.8 |
| Dose 2% (Gy) |
31.45 | 30.6 | 30.3 | 30.3 | 30.2 | 31 | 32.6 | 31.4 | 33 | 33 |
| CI | 1.80 | 1.06 | 1.99 | 2.82 | 1.14 | 1.15 | 1.09 | 1.07 | 1.01 | 1.00 |
| GM (cm) |
1.34 | 1.28 | 1.28 | 1.44 | 1.60 | 1.24 | 1.28 | 1.31 | 1.45 | 1.35 |
| OTT (minutes) |
3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
F—female; M—male; Gy—Gray; CTV—clinical target volume; ITV—internal target volume; PTV—planning target volume; tot—total (right plus left); OTT—overall treatment time.